Related Experiment Video
Updated: Apr 7, 2026

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
Published on: November 20, 2016
Non-Arteritic Anterior Ischemic Optic Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Comparative
Pareena Chaitanuwong1,2, Atitaya Piankaew1
1Ophthalmology Department, Rajavithi Hospital, Ministry of Public Health, Bangkok, Thailand.
Purpose:
Non-arteritic anterior ischemic optic neuropathy (NAION) is an ischemic disorder of the optic nerve head often associated with systemic vascular risk factors. While COVID-19 is primarily a respiratory disease, it has been linked to vascular and thromboembolic complications. This study compared the incidence, clinical characteristics, and outcomes of NAION diagnosed before and during the COVID-19 pandemic.
Patients And Methods:
A retrospective review was conducted of new NAION cases at a tertiary neuro-ophthalmology clinic diagnosed between May 2017-May 2019 (Pre-COVID) and March 2020-March 2022 (During-COVID). Data collected included demographics, vascular risk factors, clinical presentation, visual acuity, optical coherence tomography-derived retinal nerve fiber layer (RNFL) thickness, and visual field mean deviation (VF MD). Statistical analyses employed Chi-square, Fisher's exact test, t-test, and Mann-Whitney U-test.
Results:
Among 1,543 clinic patients, 46 were diagnosed with NAION (Pre-COVID: 27; During-COVID: 19). The relative frequency of NAION increased during the pandemic (3.7% vs 2.6%). Patients in the During-COVID group had significantly higher rates of hypertension (84.2% vs 40.7%, p=0.003), atherosclerotic cardiovascular disease (15.8% vs 0%, p=0.033), suspected sleep apnea (36.8% vs 0%, p=0.001), obesity (21.1% vs 0%, p=0.013), and smoking history (42.1% vs 3.7%, p=0.001). Subacute onset was more frequent during the pandemic (36.8% vs 0%, p=0.001), suggesting delayed presentation. At three months, visual acuity was worse in the During-COVID group (logMAR 1.34 vs 0.72, p=0.014). Baseline RNFL thickness and VF MD did not differ significantly. Only 31.6% of During-COVID cases had documented SARS-CoV-2 infection.
Conclusion:
During the COVID-19 period, NAION was proportionally more frequent and associated with increased vascular comorbidities, delayed presentation, and worse visual outcomes. Both direct viral and indirect pandemic-related factors may contribute.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview